tiprankstipranks
Upcoming Deadline to Share in Corcept Therapeutics Incorporated (CORT) Class Action Settlement
PremiumClass ActionUpcoming Deadline to Share in Corcept Therapeutics Incorporated (CORT) Class Action Settlement
15d ago
Corcept Therapeutics completes enrollment in Phase 3 ROSELLA trial
PremiumThe Fly
Corcept Therapeutics completes enrollment in Phase 3 ROSELLA trial
18d ago
Corcept Therapeutics completes enrollment in Phase 3 GRADIENT trial
PremiumThe Fly
Corcept Therapeutics completes enrollment in Phase 3 GRADIENT trial
25d ago
Corcept Therapeutics price target raised to $38 from $28 at H.C. Wainwright
PremiumThe FlyCorcept Therapeutics price target raised to $38 from $28 at H.C. Wainwright
2M ago
Corcept Therapeutics announces preliminary results from CATALYST study
PremiumThe Fly
Corcept Therapeutics announces preliminary results from CATALYST study
2M ago
Corcept Therapeutics reports Q4 EPS 28c, consensus 26c
PremiumThe Fly
Corcept Therapeutics reports Q4 EPS 28c, consensus 26c
2M ago
Corcept Therapeutics to Announce Fourth Quarter and Full-Year 2023 Financial Results, Provide Corporate Update and Host Conference Call
PremiumPress ReleasesCorcept Therapeutics to Announce Fourth Quarter and Full-Year 2023 Financial Results, Provide Corporate Update and Host Conference Call
3M ago
Corcept Therapeutics appoints Roberto Vieria as president, oncology
PremiumThe Fly
Corcept Therapeutics appoints Roberto Vieria as president, oncology
3M ago
Corcept Therapeutics price target lowered to $23 from $27 at Leerink
PremiumThe Fly
Corcept Therapeutics price target lowered to $23 from $27 at Leerink
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100